EVORPACEPT
UNII X7K762X1IJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Evorpacept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) X7K762X1IJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2484949-51-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

X7K762X1IJ

CAS Registry Number

2484949-51-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EVORPACEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C132851

National Cancer Institute reference terminology for clinical and research data.

INN ID

12029

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-95

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Evorpacept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EVORPACEPT

Common Names & Synonyms

1-119-SIGNAL REGULATORY PROTEIN .ALPHA. (6-ISOLEUCINE,27-ISOLEUCINE,31-PHYENYLALANINE,53-ARGININE,56-PROLINE,66-THREONINE,80-ALANINE) (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (14-ALANINE,15-ALANINE,17-ALANINE,77-ALANINE,DE-C-TERMINAL-LYSINE) (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), DIMER

CD47/SIRPA-BLOCKING AGENT ALX148

EVORPACEPT [INN]

EVORPACEPT [USAN]

EVORPACEPT [WHO-DD]

LGGL-ALX-148

SIRPA VARIANT ALX148